HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Pegram Selected Research

Plasminogen Inactivators

8/2001Her-2/neu and urokinase-type plasminogen activator and its inhibitor in breast cancer.
6/2001Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Pegram Research Topics

Disease

9Neoplasms (Cancer)
02/2012 - 10/2000
8Breast Neoplasms (Breast Cancer)
01/2022 - 02/2001
4Disease Progression
02/2012 - 02/2001
2Colorectal Neoplasms (Colorectal Cancer)
11/2004 - 01/2001
2Ovarian Neoplasms (Ovarian Cancer)
06/2001 - 05/2000
1Brain Neoplasms (Brain Tumor)
01/2022
1Epistaxis (Nosebleed)
11/2004
1Proteinuria
11/2004
1Hypertension (High Blood Pressure)
11/2004
1Stomach Neoplasms (Stomach Cancer)
08/2001
1Carcinoma (Carcinomatosis)
06/2001
1Residual Neoplasm
06/2001
1Cardiotoxicity
02/2001
1Communicable Diseases (Infectious Diseases)
01/2001
1Ovarian Epithelial Carcinoma
05/2000

Drug/Important Bio-Agent (IBA)

4Trastuzumab (Herceptin)FDA Link
01/2022 - 02/2001
4Monoclonal AntibodiesIBA
03/2010 - 10/2000
3Fluorouracil (Carac)FDA LinkGeneric
11/2004 - 01/2001
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2001 - 05/2000
3Epirubicin (Ellence)FDA LinkGeneric
09/2001 - 05/2000
3Drug CombinationsIBA
09/2001 - 05/2000
2AntibodiesIBA
09/2001 - 08/2001
2Plasminogen InactivatorsIBA
08/2001 - 06/2001
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
08/2001 - 06/2001
2Plasminogen Activator Inhibitor 1IBA
08/2001 - 06/2001
2Paclitaxel (Taxol)FDA LinkGeneric
06/2001 - 05/2000
2Carboplatin (JM8)FDA LinkGeneric
06/2001 - 05/2000
2Adenosine Triphosphate (ATP)IBA
06/2001 - 05/2000
2Pharmaceutical PreparationsIBA
06/2001 - 05/2000
1human ERBB2 proteinIBA
01/2022
1tucatinibIBA
01/2022
1Capecitabine (Xeloda)FDA Link
01/2022
1ErbB Receptors (EGF Receptor)IBA
02/2012
1epitumomabIBA
03/2010
1Bevacizumab (Avastin)FDA Link
11/2004
1Leucovorin (Folinic Acid)FDA Link
11/2004
1Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2004
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2004
1Irinotecan (Camptosar)FDA LinkGeneric
11/2004
1Methotrexate (Mexate)FDA LinkGeneric
09/2001
1Tissue ExtractsIBA
08/2001
1Complementary DNA (cDNA)IBA
08/2001
1Peptide Hydrolases (Proteases)FDA Link
08/2001
1Vinorelbine (Navelbine)FDA LinkGeneric
06/2001
1GemcitabineFDA Link
06/2001
1Growth Factor ReceptorsIBA
03/2001
1taxaneIBA
02/2001
1Docetaxel (Taxotere)FDA Link
02/2001
1AnthracyclinesIBA
02/2001
1Doxorubicin (Adriamycin)FDA LinkGeneric
02/2001
1EnzymesIBA
01/2001
1NB1011IBA
01/2001
1Thymidylate SynthaseIBA
01/2001
1Proteins (Proteins, Gene)FDA Link
10/2000
1Neoplasm Antigens (Tumor Antigens)IBA
10/2000
1Membrane Proteins (Integral Membrane Proteins)IBA
10/2000
1Antigen-Antibody Complex (Immune Complex)IBA
10/2000
1Cisplatin (Platino)FDA LinkGeneric
05/2000

Therapy/Procedure

5Drug Therapy (Chemotherapy)
02/2012 - 01/2001
3Therapeutics
02/2012 - 10/2000
1Replantation
06/2001